Loading...
Thromboresistance Comparison of the HeartMate II Ventricular Assist Device With the Device Thrombogenicity Emulation-Optimized HeartAssist 5 VAD
Approximately 7.5 × 10(6) patients in the US currently suffer from end-stage heart failure. The FDA has recently approved the designations of the Thoratec HeartMate II ventricular assist device (VAD) for both bridge-to-transplant and destination therapy (DT) due to its mechanical durability and impr...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Mechanical Engineers
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4023653/ https://ncbi.nlm.nih.gov/pubmed/24337144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1115/1.4026254 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|